Paul Tudor Jones's THC Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 9,105 shares of Tenet Healthcare Corporation (THC) worth $1.85 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in THC, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2020, adding 67,960 shares. Largest reduction occurred in Q2 2020, reducing 67,960 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Tenet Healthcare Corporation (THC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tenet Healthcare Corporation (THC) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +9,101 | Add 0.00% | 9,100 | $46.15 |
| Q3 2013 | -9,100 | Sold Out | 0 | $0.00 |
| Q4 2013 | +5,600 | New Buy | 5,600 | $42.14 |
| Q1 2014 | -5,600 | Sold Out | 0 | $0.00 |
| Q4 2014 | +8,903 | New Buy | 8,903 | $50.66 |
| Q1 2015 | -1,718 | Reduce 19.30% | 7,185 | $49.55 |
| Q2 2015 | +12,141 | Add 168.98% | 19,326 | $57.90 |
| Q3 2015 | -13,726 | Reduce 71.02% | 5,600 | $36.96 |
| Q4 2015 | +7,800 | Add 139.29% | 13,400 | $30.30 |
| Q1 2016 | -13,400 | Sold Out | 0 | $0.00 |
| Q3 2016 | +45,786 | New Buy | 45,786 | $22.67 |
| Q4 2016 | -21,486 | Reduce 46.93% | 24,300 | $14.86 |
| Q1 2017 | -24,300 | Sold Out | 0 | $0.00 |
| Q4 2017 | +31,782 | New Buy | 31,782 | $15.17 |
| Q1 2018 | +6,411 | Add 20.17% | 38,193 | $24.25 |
| Q2 2018 | -30,053 | Reduce 78.69% | 8,140 | $33.54 |
| Q3 2018 | -8,140 | Sold Out | 0 | $0.00 |
| Q4 2018 | +35,454 | New Buy | 35,454 | $17.15 |
| Q1 2019 | -35,454 | Sold Out | 0 | $0.00 |
| Q1 2020 | +67,960 | New Buy | 67,960 | $14.41 |
| Q2 2020 | -67,960 | Sold Out | 0 | $0.00 |
| Q3 2020 | +17,846 | New Buy | 17,846 | $24.49 |
| Q4 2020 | -17,846 | Sold Out | 0 | $0.00 |
| Q2 2022 | +62,302 | New Buy | 62,302 | $52.57 |
| Q3 2022 | -62,302 | Sold Out | 0 | $0.00 |
| Q2 2023 | +17,912 | New Buy | 17,912 | $81.38 |
| Q3 2023 | +18,260 | Add 101.94% | 36,172 | $65.89 |
| Q4 2023 | +17,006 | Add 47.01% | 53,178 | $75.57 |
| Q1 2024 | -53,178 | Sold Out | 0 | $0.00 |
| Q3 2024 | +5,852 | New Buy | 5,852 | $166.20 |
| Q4 2024 | -5,852 | Sold Out | 0 | $0.00 |
| Q3 2025 | +9,105 | New Buy | 9,105 | $203.04 |
Paul Tudor Jones's Tenet Healthcare Corporation Investment FAQs
Paul Tudor Jones first purchased Tenet Healthcare Corporation (THC) in Q2 2013, acquiring 9,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Tenet Healthcare Corporation (THC) for 32 quarters since Q2 2013.
Paul Tudor Jones's largest addition to Tenet Healthcare Corporation (THC) was in Q1 2020, adding 67,960 shares worth $979,000.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 9,105 shares of Tenet Healthcare Corporation (THC), valued at approximately $1.85 M.
As of the Q3 2025 filing, Tenet Healthcare Corporation (THC) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Tenet Healthcare Corporation (THC) was 67,960 shares, as reported at the end of Q1 2020.